Templeton Mary B Esq - Net Worth and Insider Trading
Templeton Mary B Esq Net Worth
The estimated net worth of Templeton Mary B Esq is at least $11 dollars as of 2024-04-23. Templeton Mary B Esq is the SVP, Gen Counsel & Corp Sec of Windtree Therapeutics Inc and owns about 2 shares of Windtree Therapeutics Inc (WINT) stock worth over $11. Details can be seen in Templeton Mary B Esq's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Templeton Mary B Esq has not made any transactions after 2020-05-22 and currently still holds the listed stock(s).
Transaction Summary of Templeton Mary B Esq
Templeton Mary B Esq Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Templeton Mary B Esq owns 1 companies in total, including Windtree Therapeutics Inc () .
Click here to see the complete history of Templeton Mary B Esq’s form 4 insider trades.
Insider Ownership Summary of Templeton Mary B Esq
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Windtree Therapeutics Inc | 2020-05-22 | Senior VP & General Counsel |
Templeton Mary B Esq Latest Holdings Summary
Templeton Mary B Esq currently owns a total of 1 stock. Templeton Mary B Esq owns 2 shares of Windtree Therapeutics Inc (WINT) as of May 22, 2020, with a value of $11.
Latest Holdings of Templeton Mary B Esq
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
WINT | Windtree Therapeutics Inc | 2020-05-22 | 2 | 5.36 | 11 |
Holding Weightings of Templeton Mary B Esq
Templeton Mary B Esq Form 4 Trading Tracker
According to the SEC Form 4 filings, Templeton Mary B Esq has made a total of 1 transactions in Windtree Therapeutics Inc (WINT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Windtree Therapeutics Inc is the acquisition of 1 shares on May 22, 2020, which cost Templeton Mary B Esq around $7,997.
Insider Trading History of Templeton Mary B Esq
- 1
Templeton Mary B Esq Trading Performance
GuruFocus tracks the stock performance after each of Templeton Mary B Esq's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Templeton Mary B Esq is 5.77%. GuruFocus also compares Templeton Mary B Esq's trading performance to market benchmark return within the same time period. The performance of stocks bought by Templeton Mary B Esq within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Templeton Mary B Esq's insider trading performs compared to the benchmark.
Performance of Templeton Mary B Esq
Average Return
Outperforming Transactions
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -9.61 | 5.77 | -16.15 | -76.41 | -73.09 | -84.54 |
Relative Return to S&P 500(%) | -15.11 | -9.18 | -36.52 | -117.03 | -88.03 | -96.9 |
Templeton Mary B Esq Ownership Network
Ownership Network List of Templeton Mary B Esq
Ownership Network Relation of Templeton Mary B Esq
Templeton Mary B Esq Owned Company Details
What does Windtree Therapeutics Inc do?
Who are the key executives at Windtree Therapeutics Inc?
Templeton Mary B Esq is the Senior VP & General Counsel of Windtree Therapeutics Inc. Other key executives at Windtree Therapeutics Inc include director & Chief Executive Officer Craig Fraser , VP & Controller & & CAO Jamie Mcandrew , and SVP & CFO John P. Hamill .
Windtree Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Templeton Mary B Esq made no insider transaction in Windtree Therapeutics Inc (). Other recent insider transactions involving Windtree Therapeutics Inc () include a net purchase of 7,812 shares made by Craig Fraser ,
In summary, during the past 3 months, insiders sold 0 shares of Windtree Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Windtree Therapeutics Inc () were sold and 434 shares were bought by its insiders, resulting in a net purchase of 434 shares.
Windtree Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Windtree Therapeutics Inc Insider Transactions
Templeton Mary B Esq Mailing Address
Above is the net worth, insider trading, and ownership report for Templeton Mary B Esq. You might contact Templeton Mary B Esq via mailing address: 2600 Kelly Rd, Warrington Pa 18976.